TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Jordyn Tarazi
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics announced granting non-qualified stock options to newly hired employees, with 23,600 shares to be vested over a four-year period under their 2024 Inducement Plan.

Insights
ALGS   neutral

The company is making a standard employee compensation move by granting stock options, which is a typical practice for attracting and retaining talent in the biotech industry